SLU-PP-322 (5 Mg)

Traditional weight-loss strategies focus on:

• Eating less (appetite suppression)

• Moving more (behavioral expenditure)

SLU-PP-322 targets a third axis: How efficiently the body converts stored fat into usable (and expendable) energy. Its design philosophy is rooted in metabolic uncoupling without systemic toxicity, aiming to increase calorie burn without stimulants, thyroid manipulation, or central nervous system stress.

A. Adipose-Selective Mitochondrial Uncoupling SLU-PP-322 influences mitochondrial efficiency within fat cells:

• Encourages mitochondria to burn fatty acids

• Reduces ATP efficiency (more fuel burned for the same output)

• Converts excess energy into heat rather than storage

This process resembles controlled thermogenesis, but without generalized overheating or sympathetic activation.

B. Preference for Fat as Fuel

• The compound promotes:

• Increased ß-oxidation of fatty acids

• Reduced reliance on glucose

Lower tendency for triglyceride re-esterification As a result, fat stores become metabolically active rather than dormant.

SLU-PP-322 produces a metabolic environment characterized by:

• Elevated baseline energy expenditure

• Reduced metabolic adaptation during caloric deficit

• Improved fat-to-energy conversion efficiency

• Minimal impact on appetite or mood signaling

This makes it fundamentally different from GLP-1-based or amylin-based agents.